Servier and Google Cloud Expand Partnership on using Data and AI
Servier to leverage Google Cloud AI across R&D, production, and distribution, accelerating digital transformation to benefit patients.These new advancements in...
Neuroscience
BioWorld by Clarivate Releases Comprehensive 2024 Year in Review
Series Recaps Biopharma, MedTech, and Science Trends and Breakthroughs That Shaped the Year LONDON, Jan. 16, 2025 /PRNewswire/ -- BioWorld™...
Apollo Neuro Partners with GOVX to Better Serve Those Who Serve Us
PITTSBURGH, Jan. 14, 2025 /PRNewswire/ -- Today, Apollo Neuroscience is proud and honored to announce our latest partnership with GOVX, an e-commerce...
Neurotechnology Boom: Brain-Computer Interface Market Forecast to Double by 2029
"Brain-Computer Interfaces (BCIs) are revolutionizing industries like healthcare, gaming, and education by enabling thought-controlled devices, opening up new business opportunities...
Sutter Health and GE HealthCare enter strategic partnership to benefit patients, physicians and clinicians with advanced, AI-powered imaging
The multi-year collaboration enables expanded access to quality diagnostic care for patients in California and provides Sutter physicians and clinicians...
Sutter Health and GE HealthCare enter strategic partnership to benefit patients, physicians and clinicians with advanced, AI-powered imaging
The multi-year collaboration enables expanded access to quality diagnostic care for patients in California and provides Sutter physicians and clinicians...
Sutter Health and GE HealthCare enter strategic partnership to benefit patients, physicians and clinicians with advanced, AI-powered imaging
The multi-year collaboration enables expanded access to quality diagnostic care for patients in California and provides Sutter physicians and clinicians...
Clinical Trial of NeuroSigma’s Monarch eTNS System for ADHD at King’s College London Completes Enrollment
ATTENS (ADHD trial of external trigeminal nerve stimulation) Project, led by Professor Katya Rubia at the Institute of Psychiatry, Psychology...
Medtronic achieves CE Mark approval for BrainSense™ Adaptive deep brain stimulation and Electrode Identifier, a groundbreaking advance in personalized, sensing-enabled care for people with Parkinson’s through innovative brain-computer interface technology
European approval introduces the world's only closed-loop DBS system with real-time, self-adjusting brain stimulation for people with Parkinson's disease GALWAY,...
Universal Brain Announces Publication of Groundbreaking Depression Research Using Multiple Event-Related Potentials
New findings support the company's neuroscience-driven approach to precision psychiatry, offering actionable insights for personalized depression treatment PALO ALTO, Calif.,...
ORYZON to Provide Corporate Progress Updates at Several Events in January-February
8th Sachs Annual Neuroscience Innovation Forum14th Annual LifeSci Advisors Corporate Access EventInvest Securities BioMed Forum 2025MidCap Events Frankfurt 2025Bio-Neuroscience 2025...
AI Wellness Unveils Mission 2025 at CES–Revolutionizing Health, Education, and Philanthropy with Digital Avatars, Wellness Bundles, and the Ask My Avatar Challenge
LAS VEGAS, Jan. 9, 2025 /PRNewswire/ -- AI Wellness (Assisted Intelligence Wellness) is taking center stage at CES 2025 with Mission...
Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219’s Transformative Potential for CNS Disorders
In the PET trial, RAP-219 achieved and exceeded target receptor occupancy, increasing support for the dosing regimen utilized in the...
ONWARD Medical Announces First Commercial Sales of ARC-EX System
UW Medicine and Next Steps Chicago both purchased systems in late December 2024 ARC-EX is the first and only FDA approved...
Hartford HealthCare and Aidoc Partner to Transform Patient Care with Enterprise AI
The partnership reached initial go-live in three weeks, showcasing the impressive speed and scalability of Aidoc's aiOS™ platform HARTFORD, Conn.,...
NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce the Initial Closing of $500,000 of the Previously Announced $1 Million Fundraising by NLS Following its Extraordinary General Meeting at a Share Price of $3.10, Representing 48% Above the Market Share Price as of Jan 6, 2025
ZURICH and NESS ZIONA, Israel, Jan. 8, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. ("NLS") (Nasdaq: NLSP), a Swiss clinical-stage biopharmaceutical...
Ensysce Biosciences Issues Annual Shareholder Letter
~ FDA Breakthrough Therapy designation received for PF614-MPAR ~~ PF614-MPAR second clinical trial initiated ~~ Lead clinical candidate identified for...
Noema Pharma Appoints Michael Samar as Chief Financial Officer
Appointment Further Strengthens Leadership Team; Follows Appointment of Volker Knappertz, M.D., as Executive Vice President of Research & DevelopmentBASEL, Switzerland,...
Gain Therapeutics Announces Formation of Clinical Advisory Board to Support Continued Advancement of Lead Drug Candidate GT-02287
BETHESDA, Md., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology...
Illumina advances NovaSeq X Series, delivering single-flow-cell system, software upgrade, and new kits to enable multiomic applications
Software upgrade advances complete workflow solutions New NovaSeq X 25B 100-cycle and 200-cycle kits enhance multiomic capabilities on NovaSeq X,...